Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rosiglitazone and cardiotoxicity--weighing the evidence.

× No keyword cloud information.

30 in total

1. Rosiglitazone: a European regulatory perspective.

Authors: E Blind; K Dunder; P A de Graeff; E Abadie
Journal: Diabetologia Date: 2010-12-14 Impact factor: 10.122

2. Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs.

Authors: Claudia Binda; Milagros Aldeco; Werner J Geldenhuys; Marcello Tortorici; Andrea Mattevi; Dale E Edmondson
Journal: ACS Med Chem Lett Date: 2011-10-15 Impact factor: 4.345

3. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

Authors: D M Nathan; J B Buse; M B Davidson; E Ferrannini; R R Holman; R Sherwin; B Zinman
Journal: Diabetologia Date: 2008-01 Impact factor: 10.122

4. Drug-related risks.

Authors: Ulrich Klotz
Journal: Eur J Clin Pharmacol Date: 2007-11 Impact factor: 2.953

5. Rosiglitazone and implications for pharmacovigilance.

Authors: Dhruv Kazi
Journal: BMJ Date: 2007-06-16

Review 6. Structural insight into function and regulation of carnitine palmitoyltransferase.

Authors: Arne C Rufer; Ralf Thoma; Michael Hennig
Journal: Cell Mol Life Sci Date: 2009-05-09 Impact factor: 9.261

Review 7. Vascular disease and cognitive impairment.

Authors: Christiane Reitz; José A Luchsinger; Richard Mayeux
Journal: Expert Rev Neurother Date: 2008-08 Impact factor: 4.618

8. Safety and Efficacy of D-Tagatose in Glycemic Control in Subjects with Type 2 Diabetes.

Authors: Mark Ensor; Amy B Banfield; Rebecca R Smith; Jarrod Williams; Robert A Lodder
Journal: J Endocrinol Diabetes Obes Date: 2014-12-31

Review 9. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.

Authors: José Alejandro Luchsinger
Journal: Eur J Pharmacol Date: 2008-03-04 Impact factor: 4.432

10. Thiazolidinediones and cardiovascular risk - a question of balance.

Authors: Erland Erdmann; Bernard Charbonnel; Robert Wilcox
Journal: Curr Cardiol Rev Date: 2009-08